Worldwide: Food, Drugs, Healthcare, Life Sciences

As pharmaceutical and biotech companies increasingly leverage AI and machine learning to accelerate drug discovery and develop personalized therapies, data has become one of the most valuable assets in life sciences transactions. Understanding the legal and commercial implications of data scope, ownership, and usage restrictions is now essential for dealmakers navigating this evolving landscape where proprietary research...

On September 15, 2026, a dozen independent pharmacies in Arkansas filed a lawsuit against Express Scripts Inc. (ESI), a pharmacy benefit manager (PBM), alleging that it reimbursed the pharmacies...

Bristol-Myers Squibb and Ono Pharmaceutical have filed a patent infringement lawsuit against Amgen over its proposed nivolumab biosimilar ABP 206, asserting seven patents related to OPDIVO. The complaint follows earlier inter partes review challenges and patent dance negotiations that narrowed the dispute to specific claims covering the antibody sequence, cancer treatment methods, and dosing regimens.

Catering liquor and beer license holders in Nashville must navigate two distinct regulatory frameworks: Metro Nashville's distance restrictions for beer catering permits and Tennessee state limitations on catering liquor licenses. Understanding these rules is essential to avoid compliance issues and ensure events proceed smoothly, particularly when venues are near schools, places of worship, or Metro parks.

On September 15, 2026, a dozen independent pharmacies in Arkansas filed a lawsuit against Express Scripts Inc. (ESI), a pharmacy benefit manager (PBM), alleging that it reimbursed the pharmacies...

Over the past year, industry has had a front row seat as the Food and Drug Administration (“FDA” or the “Agency”) decides just how much leeway it wants to afford the manufacture, marketing, and sale of peptide products, and just where it wants to draw the line. Despite the recent decision of FDA’s Pharmacy Compounding Advisory Committee (“PCAC”) to recommend a number of peptides for inclusion on the 503A bulks list process — a move that represents a potentially more permissive stance toward peptide regulation, at least in terms of what can and cannot be compounded under 503A...

CMS is expanding its ACCESS Model in spring 2027 to include five new tracks covering heart failure, COPD, substance use disorders, tobacco cessation, and extended musculoskeletal support. The expansion emphasizes symptom management, quality of life, and technology-enabled care for individuals with serious or chronic conditions, creating meaningful new pathways for palliative-style care within Medicare reimbursement. With 160 participating organizations and major health payers pledging to adopt outcomes-base

New policies and technology now enable the government to detect healthcare fraud at scale and speed, raising the stakes for companies and investors. Advanced artificial intelligence tools and cross-agency data sharing have transformed enforcement capabilities, creating new exposure risks for healthcare and life sciences companies that depend on government payments.

AI’s greatest near-term impact in many healthcare organizations may be in administration, particularly as financial pressures persist and experienced employees continue to be difficult to recruit and retain in the industry.